SK609 HCl

CAS No. 1092797-77-7

SK609 HCl( —— )

Catalog No. M34027 CAS No. 1092797-77-7

SK609 HCl (SK609 hydrochloride) is a dopamine D3 receptor (D3R) selective agonist that inhibits norepinephrine transporter proteins and can be used to study Parkinson's disease and cognitive disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 122 Get Quote
5MG 186 Get Quote
10MG 274 Get Quote
25MG 453 Get Quote
50MG 632 Get Quote
100MG 875 Get Quote
500MG 1737 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SK609 HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    SK609 HCl (SK609 hydrochloride) is a dopamine D3 receptor (D3R) selective agonist that inhibits norepinephrine transporter proteins and can be used to study Parkinson's disease and cognitive disorders.
  • Description
    SK609 hydrochloride is a dopamine D3 receptor (D3R) selective agonist with an EC50 of 1109 nM. SK609 hydrochloride has the potential for parkinson research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    Dopamine Receptor | Norepinephrine
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1092797-77-7
  • Formula Weight
    220.14
  • Molecular Formula
    C10H15Cl2N
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.ClC=1C=CC=CC1CCC(N)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wei Xu, et al. Functional Characterization of a Novel Series of Biased Signaling Dopamine D3 Receptor Agonists. ACS Chem Neurosci. 2017 Mar 15;8(3):486-500.?
molnova catalog
related products
  • NGD 94-1

    NGD 94-1 is a selective D4 receptor antagonist with an affinity of 3 nM for the D4 receptor and greater than 2 pM for the D1, D2, D3, and D5 receptors.

  • GBR-12935

    GBR 12935 induced increase in the extracellular levels of dopamine to basal levels.

  • ONC206

    ONC206 is an analogue of TRAIL inducer ONC201 and is a selective antagonist of the D2-like dopamine receptors (DRD2/3/4) at nanomolar concentrations. ONC206 also has broad-spectrum anti-tumor activity. ONC206 (Oncoceutics) is an imipiridone with nanomolar potency and analogue of ONC201, a selective dopamine receptor D2 (DRD2) antagonist currently being investigated in phase II clinical trials for serous endometrial cancer (SEC).??